Zhao et al. also showed that treating MDA-MB-231 cancer cells with 2-hydroxypropyl-β-cyclodextrin leads to the upregulation of cholesterol synthesis and LDLR, as well as reduced ABCA1 expression [35]. The gene discussed is LDLR; the disease is cancer.